An Act relative to the administration of anti-psychotic or other psychotropic substances to nursing home residents
Accompanied a study order, see H5338 (under House Rule 27)
Email me when H 2216 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track H 2216. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill amends Massachusetts law to define psychotropic drugs and to obligate nursing homes to submit quarterly medication reports, post them publicly, and include detailed consent information in each resident’s care plan. It targets nursing homes, their residents, and prescribing clinicians to increase transparency and accountability for these medications.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about H 2216
3 free questions a day, no accountHearings
- Patient Rights and Carceral HealthJoint Committee on Mental Health, Substance Use and Recovery · Oct 14, 2025
History
- Accompanied a study order, see H5338 (under House Rule 27)
- Reporting date extended to Wednesday, March 18, 2026
- Hearing scheduled for 10/14/2025 from 01:00 PM-05:00 PM in A-2
- Senate concurred
- Referred to the committee on Mental Health, Substance Use and Recovery
Sponsors
- Sally Kerans (D) · sponsor
- Carmine Lawrence Gentile
- James B. Eldridge
- John Francis Moran
- Natalie M. Higgins
- Sally P. Kerans
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when H 2216 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track H 2216 freeOr ask your AI assistant about H 2216 directly:
Add to Claude, ChatGPT or Cursor